Effective Treatment of Low-Dose Decitabine in Myelodysplastic Syndrome/Myeloproliferative Neoplasms

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s142561
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Characteristics of the Four Subtypes of Myelodysplastic/Myeloproliferative Neoplasms

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

1. Pathophysiology and Treatment Strategies of Myeloproliferative Neoplasms

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

An Exciting New Era in the Treatment of Myeloproliferative Neoplasms

Oncology & Hematology Review (US)
2016English

Routine Blood Examinations Combined With Morphological Analysis for the Diagnosis of Myelodysplastic/Myeloproliferative Neoplasms

Oncology Letters
Cancer ResearchOncology
2016English

Ruxolitinib Treatment and Risk of B‐cell Lymphomas in Myeloproliferative Neoplasms

American Journal of Hematology
Hematology
2019English

Histological Evaluation of Myeloproliferative Neoplasms

Journal of clinical and experimental hematopathology : JCEH
Medicine
2018English

DNMT3A Mutations in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Italian Survey on Clinical Practice in Myeloproliferative Neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party Initiative

American Journal of Hematology
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy